Literature DB >> 15633098

Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.

James M Stark1, Amir M Khan, Constance L Chiappetta, Hasen Xue, Joseph L Alcorn, Giuseppe N Colasurdo.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) infection of respiratory epithelial cell cultures increases expression of inducible nitric oxide synthase (iNOS). The present study was designed to evaluate both the effect of RSV infection on expression of iNOS and the role of NO in the host responses to RSV infection in vivo.
METHODS: RSV infection was performed by nasal inoculation of BALB/c mice (6-8 weeks old). Total cell and differential counts were measured in bronchoalveolar lavage (BAL) fluid. Lung nitrates were measured in BAL fluid by use of the Greiss reaction, and cytokines were measured by enzyme-linked immunosorbent assay. Lung hyperresponsiveness to methacholine was measured by use of a Buxco unrestrained whole-body plethysmograph.
RESULTS: RSV infection increased levels of lung nitrites, levels of iNOS protein and activity, and levels of iNOS mRNA. RSV infection resulted in recruitment of neutrophils and lymphocytes into the lungs, enhanced levels of interferon (IFN)-gamma, and increased airway hyperresponsiveness (AHR). Treatment with iNOS inhibitors (2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine and N-nitro-L-arginine methyl ester) increased RSV titers in the lungs yet reduced lung inflammation and RSV-induced AHR. Inhibition of iNOS activity with either agent did not significantly alter levels of IFN-gamma or interleukin-4 in the lungs.
CONCLUSIONS: The results of the present study suggest that RSV-induced production of NO participates in complex host responses and may mediate important aspects of the clinical disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15633098     DOI: 10.1086/427241

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Authors:  Michael E Speer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  KLF6 and iNOS regulates apoptosis during respiratory syncytial virus infection.

Authors:  Victoria Mgbemena; Jesus Segovia; Te-Hung Chang; Santanu Bose
Journal:  Cell Immunol       Date:  2013-06-18       Impact factor: 4.868

3.  Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation.

Authors:  Shawn Monique Castro; Antonieta Guerrero-Plata; Giovanni Suarez-Real; Patrick A Adegboyega; Giuseppe N Colasurdo; Amir M Khan; Roberto P Garofalo; Antonella Casola
Journal:  Am J Respir Crit Care Med       Date:  2006-09-28       Impact factor: 21.405

4.  Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide.

Authors:  L Hobson; M L Everard
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

5.  Toll-like receptor 7 rapidly relaxes human airways.

Authors:  Matthew G Drake; Gregory D Scott; Becky J Proskocil; Allison D Fryer; David B Jacoby; Elad H Kaufman
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

6.  Human and Mouse Eosinophils Have Antiviral Activity against Parainfluenza Virus.

Authors:  Matthew G Drake; Elizabeth R Bivins-Smith; Becky J Proskocil; Zhenying Nie; Gregory D Scott; James J Lee; Nancy A Lee; Allison D Fryer; David B Jacoby
Journal:  Am J Respir Cell Mol Biol       Date:  2016-09       Impact factor: 6.914

Review 7.  The aryl hydrocarbon receptor is a modulator of anti-viral immunity.

Authors:  Jennifer L Head; B Paige Lawrence
Journal:  Biochem Pharmacol       Date:  2008-11-05       Impact factor: 5.858

Review 8.  Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.

Authors:  Roberto P Garofalo; Deepthi Kolli; Antonella Casola
Journal:  Antioxid Redox Signal       Date:  2012-09-07       Impact factor: 8.401

9.  Nitric oxide metabolites as biomarkers for influenza-like acute respiratory infections presenting to the emergency room.

Authors:  Asad I Mian; Federico R Laham; Andrea T Cruz; Harsha Garg; Charles G Macias; A Chantal Caviness; Pedro A Piedra
Journal:  Open Respir Med J       Date:  2012-11-14

Review 10.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.